SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001019155-15-000315
Filing Date
2015-09-21
Accepted
2015-09-21 16:48:54
Documents
3
Effectiveness Date
2015-09-21

Document Format Files

Seq Description Document Type Size
1 POST EFFECTIVE AMENDMENT NO. 1 TO THE FORM F-6 naba125901f6pos1.htm F-6 POS 30371
2 FORM OF DEPOSIT AGREEMENT nabrivadepnrec.htm EX-1 251450
3 CERTIFICATION UNDER RULE 466 nabriva466.htm EX-5 2567
  Complete submission text file 0001019155-15-000315.txt   286076
Mailing Address ATTN: THERESA BOTROS - 15EAST 101 BARCLAY STREET NYC NY 10286
Business Address AMERICAN DEPOSITARY RECEIPTS DIVISION 101 BARCLAY STREET - 22WEST NYC NY 10286 212-815-4601
BANK OF NEW YORK / ADR DIVISION (Filed by) CIK: 0001201935 (see all company filings)

IRS No.: 135160382 | State of Incorp.: NY
Type: F-6 POS
SIC: 8880 American Depositary Receipts

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-206771 | Film No.: 151117795
SIC: 2834 Pharmaceutical Preparations